NYSE: BXCBluelinx Holdings Inc Stock
$65.14-7.19 (-9.94%)
Updated Apr 30, 2025
BXC Price
$65.14
Fair Value Price
N/A
Market Cap
$522.57M
52 Week Low
$63.55
52 Week High
$134.79
P/E
14.35x
P/B
0.82x
P/S
0.22x
PEG
N/A
Dividend Yield
N/A
Revenue
$2.94B
Earnings
$38.43M
Gross Margin
16.1%
Operating Margin
2.49%
Profit Margin
1.3%
Debt to Equity
1.57
Operating Cash Flow
$82M
Beta
1.67
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
BXC Overview
BlueLinx Holdings Inc is a wholesale distributor of building products in the U.S. Offerings include engineered wood, moulding, siding, metal, and insulation products primarily used for structural support in construction projects. The company serves dealers, specialty distributors, national home centers, and manufactured housing customers through a network of distribution centers. BlueLinx was formed in 2004 and is headquartered in Atlanta, GA.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine BXC's potential to beat the market
CHold
- Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More
Zen Rating Component Grades
C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Industrial Distribution
Industry Rating
C
BXC
Ranked#14 of 18
Ranked#14 of 18
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $88.46 | A | |
| $16.13 | B | |
| $25.68 | C |
Be the first to know about important BXC news, forecast changes, insider trades & much more!
BXC News
Overview
Due Diligence Score
–
Industry Average (38)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how BXC scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
BXC was unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
BXC is good value based on its earnings relative to its share price (14.35x), compared to the US market average (29.18x)
P/E vs Market Valuation
BXC is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 30 more BXC due diligence checks available for Premium users.
Valuation
BXC price to earnings (PE)
For valuing profitable companies with steady earnings
Company
14.35x
Industry
27.82x
Market
29.18x
BXC is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
BXC is good value based... subscribe to Premium to read more.
P/E vs Market Valuation
BXC price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
0.82x
Industry
6.4x
BXC is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
BXC's financial health
Profit margin
Revenue
$709.2M
Net Income
$2.8M
Profit Margin
0.4%
BXC's Earnings (EBIT) of $73.11M... subscribe to Premium to read more.
Interest Coverage Financials
BXC's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$1.6B
Liabilities
$997.4M
Debt to equity
1.57
BXC's short-term assets ($1.17B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
BXC's short-term assets ($1.17B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
BXC's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
BXC's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$33.9M
Investing
-$3.4M
Financing
-$19.3M
BXC's operating cash flow ($82.41M)... subscribe to Premium to read more.
Debt Coverage Financials
BXC vs Industrial Distribution Stocks
Bluelinx Holdings Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.